Hose, D., Ray, S., Rößler, S., Thormann, U., Schnettler, R., De Veirman, K., . . . Alt, V. (2024). Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma. Journal of hematology & oncology, 17, . https://doi.org/10.1186/s13045-024-01636-4
Chicago Style (17th ed.) CitationHose, Dirk, et al. "Bortezomib-releasing Silica-collagen Xerogels for Local Treatment of Osteolytic Bone- and Minimal Residual Disease in Multiple Myeloma." Journal of Hematology & Oncology 17 (2024). https://doi.org/10.1186/s13045-024-01636-4.
MLA (9th ed.) CitationHose, Dirk, et al. "Bortezomib-releasing Silica-collagen Xerogels for Local Treatment of Osteolytic Bone- and Minimal Residual Disease in Multiple Myeloma." Journal of Hematology & Oncology, vol. 17, 2024, https://doi.org/10.1186/s13045-024-01636-4.